HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.

AbstractINTRODUCTION:
We examined neuropsychiatric symptoms (NPS) and psychotropic medication use in a large sample of individuals with early-onset Alzheimer's disease (EOAD; onset 40-64 years) at the midway point of data collection for the Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
METHODS:
Baseline NPS (Neuropsychiatric Inventory - Questionnaire; Geriatric Depression Scale) and psychotropic medication use from 282 participants enrolled in LEADS were compared across diagnostic groups - amyloid-positive EOAD (n = 212) and amyloid negative early-onset non-Alzheimer's disease (EOnonAD; n = 70).
RESULTS:
Affective behaviors were the most common NPS in EOAD at similar frequencies to EOnonAD. Tension and impulse control behaviors were more common in EOnonAD. A minority of participants were using psychotropic medications, and use was higher in EOnonAD.
DISCUSSION:
Overall NPS burden and psychotropic medication use were higher in EOnonAD than EOAD participants. Future research will investigate moderators and etiological drivers of NPS, and NPS differences in EOAD versus late-onset AD.
AuthorsAngelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, Alex Pena Garcia, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Sophia Wang, Kala Kirby, Paige E Logan, Paul Aisen, Jeffrey L Dage, Tatiana Foroud, Percy Griffin, Leonardo Iaccarino, Joel H Kramer, Robert Koeppe, Walter A Kukull, Renaud La Joie, Nidhi S Mundada, Melissa E Murray, Kelly Nudelman, David N Soleimani-Meigooni, Malia Rumbaugh, Arthur W Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S Day, Ranjan Duara, Neill R Graff-Radford, Lawrence S Honig, David T Jones, Joseph Masdeu, Mario F Mendez, Kyle Womack, Erik Musiek, Chiadi U Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon J Sha, Raymond S Turner, Thomas S Wingo, David A Wolk, Maria C Carrillo, Bradford C Dickerson, Gil D Rabinovici, Liana G Apostolova, LEADS Consortium
JournalAlzheimer's & dementia : the journal of the Alzheimer's Association (Alzheimers Dement) Vol. 19 Suppl 9 Pg. S42-S48 (11 2023) ISSN: 1552-5279 [Electronic] United States
PMID37296082 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Topics
  • Humans
  • Aged
  • Alzheimer Disease (drug therapy, psychology)
  • Longitudinal Studies
  • Data Collection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: